A phase IIa study of MYDICAR in end-stage renal disease patients undergoing surgery for arteriovenous fistula creation in preparation for haemodialysis
Latest Information Update: 19 Aug 2014
At a glance
- Drugs SERCA 2a gene therapy (Primary)
- Indications Renal failure
- Focus Therapeutic Use
Most Recent Events
- 19 Aug 2014 New trial record